Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Viral conjunctivitis therapeutics is undergoing a transitional phase. Currently, there is no drug available for the treatment of viral conjunctivitis. However, the presence of a robust pipeline indicates towards a thriving future.
The global market for viral conjunctivitis pipeline drugs is likely to exhibit a thumping CAGR of 69.60% between 2019 and 2026 and reach an opportunity worth US$462.4 mn by the end of the forecast period. The increasing investments from ophthalmic drug manufacturers for the development of efficient treatment for viral conjunctivitis, coupled with the increasing awareness among people and augmenting expenditure on healthcare, are accelerating the growth rate of this market significantly.
This report elaborates on the current development of the Viral Conjunctivitis Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Novartis
Panoptes Pharma
Adenovir Pharma
NovaBay Pharmaceuticals
NanoViricides
Shire
NicOx
By Type:
APD-209
FST-100
By Application:
ASCs
Hospitals
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Viral Conjunctivitis Drugs Market Overview 2018-2029
-
1.1 China Viral Conjunctivitis Drugs Industry Development Overview
-
1.2 China Viral Conjunctivitis Drugs Industry Development History
-
1.3 China Viral Conjunctivitis Drugs Industry Market Size (2018-2029)
-
1.4 China Viral Conjunctivitis Drugs Market Analysis by Type from Production Side
-
1.4.1 China Viral Conjunctivitis Drugs Production Volume, Production Value and Growth Rate of APD-209 (2018-2029)
-
1.4.2 China Viral Conjunctivitis Drugs Production Volume, Production Value and Growth Rate of FST-100 (2018-2029)
-
1.5 China Viral Conjunctivitis Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Viral Conjunctivitis Drugs Sales Volume, Sales Value and Growth Rate of ASCs (2018-2029)
-
1.5.2 China Viral Conjunctivitis Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
1.6 China Viral Conjunctivitis Drugs Market Analysis by Region
-
1.6.1 North China Viral Conjunctivitis Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Viral Conjunctivitis Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Viral Conjunctivitis Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Viral Conjunctivitis Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Viral Conjunctivitis Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Viral Conjunctivitis Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Viral Conjunctivitis Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Viral Conjunctivitis Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Viral Conjunctivitis Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Viral Conjunctivitis Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Viral Conjunctivitis Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Viral Conjunctivitis Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Viral Conjunctivitis Drugs Industry Development
Chapter 3 Viral Conjunctivitis DrugsIndustry Chain Analysis
-
3.1 Viral Conjunctivitis Drugs Industry Chain
-
3.2 Viral Conjunctivitis Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Viral Conjunctivitis Drugs Market
-
3.3 Viral Conjunctivitis Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Viral Conjunctivitis Drugs Market
Chapter 4 China Viral Conjunctivitis Drugs Market, by Type
-
4.1 China Viral Conjunctivitis Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Viral Conjunctivitis Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Viral Conjunctivitis Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Viral Conjunctivitis Drugs Production Volume and Growth Rate of APD-209
-
4.5.2 China Viral Conjunctivitis Drugs Production Volume and Growth Rate of FST-100
Chapter 5 China Viral Conjunctivitis Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Viral Conjunctivitis Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Viral Conjunctivitis Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Viral Conjunctivitis Drugs Market Size and Growth Rate of ASCs
-
5.5.2 China Viral Conjunctivitis Drugs Market Size and Growth Rate of Hospitals
Chapter 6 China Viral Conjunctivitis Drugs Market, by Region
-
6.1 China Viral Conjunctivitis Drugs Production Volume and Production Value, by Region
-
6.2 China Viral Conjunctivitis Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Viral Conjunctivitis Drugs Market Analysis
-
7.1 North China Viral Conjunctivitis Drugs Market, by Type
-
7.2 North China Viral Conjunctivitis Drugs Market, by Application
Chapter 8 Central China Viral Conjunctivitis Drugs Market Analysis
-
8.1 Central China Viral Conjunctivitis Drugs Market, by Type
-
8.2 Central China Viral Conjunctivitis Drugs Market, by Application
Chapter 9 South China Viral Conjunctivitis Drugs Market Analysis
-
9.1 South China Viral Conjunctivitis Drugs Market, by Type
-
9.2 South China Viral Conjunctivitis Drugs Market, by Application
Chapter 10 East China Viral Conjunctivitis Drugs Market Analysis
-
10.1 East China Viral Conjunctivitis Drugs Market, by Type
-
10.2 East China Viral Conjunctivitis Drugs Market, by Application
Chapter 11 Northeast China Viral Conjunctivitis Drugs Market Analysis
-
11.1 Northeast China Viral Conjunctivitis Drugs Market, by Type
-
11.2 Northeast China Viral Conjunctivitis Drugs Market, by Application
Chapter 12 Southwest China Viral Conjunctivitis Drugs Market Analysis
-
12.1 Southwest China Viral Conjunctivitis Drugs Market, by Type
-
12.2 Southwest China Viral Conjunctivitis Drugs Market, by Application
Chapter 13 Northwest China Viral Conjunctivitis Drugs Market Analysis
-
13.1 Northwest China Viral Conjunctivitis Drugs Market, by Type
-
13.2 Northwest China Viral Conjunctivitis Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 Novartis
-
14.1.1 Novartis Company Profile
-
14.1.2 Novartis Viral Conjunctivitis Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Panoptes Pharma
-
14.2.1 Panoptes Pharma Company Profile
-
14.2.2 Panoptes Pharma Viral Conjunctivitis Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Adenovir Pharma
-
14.3.1 Adenovir Pharma Company Profile
-
14.3.2 Adenovir Pharma Viral Conjunctivitis Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 NovaBay Pharmaceuticals
-
14.4.1 NovaBay Pharmaceuticals Company Profile
-
14.4.2 NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 NanoViricides
-
14.5.1 NanoViricides Company Profile
-
14.5.2 NanoViricides Viral Conjunctivitis Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Shire
-
14.6.1 Shire Company Profile
-
14.6.2 Shire Viral Conjunctivitis Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 NicOx
-
14.7.1 NicOx Company Profile
-
14.7.2 NicOx Viral Conjunctivitis Drugs Market Performance
-
14.7.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Viral Conjunctivitis Drugs Industry Research Conclusions
-
15.2 Viral Conjunctivitis Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Viral Conjunctivitis Drugs Industry Market Size (2018-2029)
-
Figure China Viral Conjunctivitis Drugs Production Volume, Production Value and Growth Rate of APD-209 (2018-2029)
-
Figure China Viral Conjunctivitis Drugs Production Volume, Production Value and Growth Rate of FST-100 (2018-2029)
-
Figure China Viral Conjunctivitis Drugs Sales Volume, Sales Value and Growth Rate of ASCs (2018-2029)
-
Figure China Viral Conjunctivitis Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
Figure North China Viral Conjunctivitis Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Viral Conjunctivitis Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Viral Conjunctivitis Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Viral Conjunctivitis Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Viral Conjunctivitis Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Viral Conjunctivitis Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Viral Conjunctivitis Drugs Market Size and Growth Rate from 2018-2029
-
Figure Viral Conjunctivitis Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Viral Conjunctivitis Drugs Market Share by Type in 2018
-
Figure China Viral Conjunctivitis Drugs Market Share by Type in 2023
-
Figure China Viral Conjunctivitis Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Viral Conjunctivitis Drugs Production Volume and Growth Rate of APD-209 (2018-2023)
-
Figure China Viral Conjunctivitis Drugs Production Volume and Growth Rate of FST-100 (2018-2023)
-
Figure China Viral Conjunctivitis Drugs Market Share by Application in 2018
-
Figure China Viral Conjunctivitis Drugs Market Share by Application in 2023
-
Figure China Viral Conjunctivitis Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Viral Conjunctivitis Drugs Market Size and Growth Rate of ASCs (2018-2023)
-
Figure China Viral Conjunctivitis Drugs Market Size and Growth Rate of Hospitals (2018-2023)
-
Table China Viral Conjunctivitis Drugs Production Volume by Region (2018-2023)
-
Table China Viral Conjunctivitis Drugs Production Volume Share by Region (2018-2023)
-
Figure China Viral Conjunctivitis Drugs Production Volume Share by Region (2018-2023)
-
Table China Viral Conjunctivitis Drugs Production Value by Region (2018-2023)
-
Table China Viral Conjunctivitis Drugs Production Value Share by Region (2018-2023)
-
Figure China Viral Conjunctivitis Drugs Production Value Share by Region (2018-2023)
-
Table China Viral Conjunctivitis Drugs Sales Volume by Region (2018-2023)
-
Table China Viral Conjunctivitis Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Viral Conjunctivitis Drugs Sales Volume Share by Region (2018-2023)
-
Table China Viral Conjunctivitis Drugs Sales Value by Region (2018-2023)
-
Table China Viral Conjunctivitis Drugs Sales Value Share by Region (2018-2023)
-
Figure China Viral Conjunctivitis Drugs Sales Value Share by Region (2018-2023)
-
Table North China Viral Conjunctivitis Drugs Production Volume by Type (2018-2023)
-
Table North China Viral Conjunctivitis Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Viral Conjunctivitis Drugs Production Volume Share by Type (2018-2023)
-
Table North China Viral Conjunctivitis Drugs Sales Volume by Application (2018-2023)
-
Table North China Viral Conjunctivitis Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Viral Conjunctivitis Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Viral Conjunctivitis Drugs Production Volume by Type (2018-2023)
-
Table Central China Viral Conjunctivitis Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Viral Conjunctivitis Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Viral Conjunctivitis Drugs Sales Volume by Application (2018-2023)
-
Table Central China Viral Conjunctivitis Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Viral Conjunctivitis Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Viral Conjunctivitis Drugs Production Volume by Type (2018-2023)
-
Table South China Viral Conjunctivitis Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Viral Conjunctivitis Drugs Production Volume Share by Type (2018-2023)
-
Table South China Viral Conjunctivitis Drugs Sales Volume by Application (2018-2023)
-
Table South China Viral Conjunctivitis Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Viral Conjunctivitis Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Viral Conjunctivitis Drugs Production Volume by Type (2018-2023)
-
Table East China Viral Conjunctivitis Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Viral Conjunctivitis Drugs Production Volume Share by Type (2018-2023)
-
Table East China Viral Conjunctivitis Drugs Sales Volume by Application (2018-2023)
-
Table East China Viral Conjunctivitis Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Viral Conjunctivitis Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Viral Conjunctivitis Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Viral Conjunctivitis Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Viral Conjunctivitis Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Viral Conjunctivitis Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Viral Conjunctivitis Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Viral Conjunctivitis Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Viral Conjunctivitis Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Viral Conjunctivitis Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Viral Conjunctivitis Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Viral Conjunctivitis Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Viral Conjunctivitis Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Viral Conjunctivitis Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Viral Conjunctivitis Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Viral Conjunctivitis Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Viral Conjunctivitis Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Viral Conjunctivitis Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Viral Conjunctivitis Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Viral Conjunctivitis Drugs Sales Volume Share by Application (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Viral Conjunctivitis Drugs Revenue, Price and Gross (2018-2023)
-
Table Panoptes Pharma Company Profile
-
Table Panoptes Pharma Viral Conjunctivitis Drugs Revenue, Price and Gross (2018-2023)
-
Table Adenovir Pharma Company Profile
-
Table Adenovir Pharma Viral Conjunctivitis Drugs Revenue, Price and Gross (2018-2023)
-
Table NovaBay Pharmaceuticals Company Profile
-
Table NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Revenue, Price and Gross (2018-2023)
-
Table NanoViricides Company Profile
-
Table NanoViricides Viral Conjunctivitis Drugs Revenue, Price and Gross (2018-2023)
-
Table Shire Company Profile
-
Table Shire Viral Conjunctivitis Drugs Revenue, Price and Gross (2018-2023)
-
Table NicOx Company Profile
-
Table NicOx Viral Conjunctivitis Drugs Revenue, Price and Gross (2018-2023)
-
